发明名称 |
COMPOUNDS AND METHOD FOR TREATMENT OF CANCER |
摘要 |
The invention relates to a compound of Formula (I) and/or a pharmaceutically-acceptable salt, hydrate, solvate, tautomer, optical isomer, E-isomer, Z-isomer, or combination thereof, wherein X is selected from S or O; R5 is selected from a substituted or unsubstituted aromatic group, a substituted or unsubstituted heteroaromatic group, or (Formula II) and the remaining substituents are described herein; and a composition comprising the thiosemicarbazone and/or the semicarbazone. The invention also relates to a method of administration of a thiocarbazone and/or a semicarbazone; and use thereof to treat a cancer. |
申请公布号 |
WO2009079797(A1) |
申请公布日期 |
2009.07.02 |
申请号 |
WO2008CA02293 |
申请日期 |
2008.12.24 |
申请人 |
CRITICAL OUTCOME TECHNOLOGIES, INC.;DANTER, WAYNE R.;LAU, CHEUK, KUN |
发明人 |
DANTER, WAYNE R.;LAU, CHEUK, KUN |
分类号 |
C07D403/12;A61K31/50;A61K31/501;A61P35/00;C07D237/08;C07D401/14 |
主分类号 |
C07D403/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|